Press Release
Jan 09, 2023
Chris Martin | Cmartin@davidjamesgroup.com | 630.670.2745
DENVER (Jan. 6, 2023) – The JTO Clinical and Research Reports has named Dr. Emily Stone as its new editor-in-chief. The JTO CCR is the official open-access journal of The International Association for the Study of Lung Cancer (IASLC).
Dr. Stone is a consultant respiratory physician and head of Thoracic Medicine within the Department of Thoracic Medicine and Lung Transplantation at St Vincent’s Hospital in Sydney, Australia, where she established a clinic to treat lung cancer. She is also the founding and immediate past chair of the St. Vincent’s Hospital Lung Cancer Multidisciplinary Team.
Dr. Stone is the NSW Principal Investigator for the International Lung Screen Trial (ILST) investigating optimal strategies in low-dose CT screening for lung cancer and is CIB for the NHMRC-funded Care to Quit trial investigating smoking cessation in cancer clinics. She serves as the deputy board chair of the Thoracic Oncology Group of Australasia and the immediate past head of the APSR Lung Cancer Assembly and Group Head APSR.
She has extensive journal editing experience, which includes past roles as associate editor of the Journal of Thoracic Oncology, associate editor of the Journal of Thoracic Oncology Clinical and Research Reports, and deputy editor of Respirology.
She earned a Ph.D. from the University of Sydney in Clinical Data Science in Lung Cancer Multidisciplinary Care, following a 2021 Master of Medicine from the University of Sydney in Pulmonary Fibrosis, Bleomycin, and Growth Factors. She served as a Fellow in the Royal Australasian College of Physicians and earned her MBBS from the University of Sydney in 1993.
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to studying lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the JTO Clinical and Research Reports
JTO Clinical and Research Reports is the official open-access journal of the International Association for the Study of Lung Cancer. It aims to complement the Journal of Thoracic Oncology by offering authors a gold open-access publication option and publishing the following article types in particular:
- Phase I trials
- Well-performed single-arm phase II trials
- Subset analyses of published trials
- Impactful retrospective studies
- Database analysis
- Large institutional series
- High-quality case reports
- Region-specific clinical trials
- Subspecialty thoracic oncology studies
- Selected high-quality meeting reports
As an open-access journal with no subscription charges, JTO CRR requires authors to pay a fee to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone. To learn more, visit https://www.jtocrr.org.
###